Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors

Neuropsychopharmacology

Volumn 40, Issue 1, 2015, Pages 88-112

  Suri, Deepika ^a   Teixeira, Cátia M ^a   Cagliostro, Martha K Caffrey ^a   Mahadevia, Darshini ^a   Ansorge, Mark S ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOGENIC AMINE;

ADULT; ANIMAL; BRAIN; COGNITION; EMOTION; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; NERVE CELL PLASTICITY; PHYSIOLOGY;

ADULT; ANIMALS; BIOGENIC MONOAMINES; BRAIN; COGNITION; EMOTIONS; HUMANS; NEURONAL PLASTICITY;

EID: 84921495067     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.231     Document Type: Review

References (430)

1. Adamec R, Burton P, Blundell J, Murphy DL, Holmes A (2006). Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res 170: 126-140.
2. Aguilar MA, Minarro J, Perez-Iranzo N, Simon VM (1994). Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacol Biochem Behav 47: 753-756.
3. Alenina N, Kikic D, Todiras M, Mosienko V, Qadri F, Plehm R et al (2009). Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Natl Acad Sci USA 106: 10332-10337.
4. Alvarez C, Vitalis T, Fon EA, Hanoun N, Hamon M, Seif I et al (2002). Effects of genetic depletion of monoamines on somatosensory cortical development. Neuroscience 115: 753-764.
5. Andersen SL (2005). Stimulants and the developing brain. Trends Pharmacol Sci 26: 237-243.
6. Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WA Jr. (2002). Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 5: 13-14.
7. Andersen SL, Napierata L, Brenhouse HC, Sonntag KC (2008). Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors. Eur J Neurosci 27: 2962-2972.
8. Andersen SL, Sonntag KC (2014). Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood. Front Synaptic Neurosci 6: 1.
9. Anderson AD, Oquendo MA, Parsey RV, Milak MS, Campbell C, Mann JJ (2004). Regional brain responses to serotonin in major depressive disorder. J Affect Disord 82: 411-417.
10. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D et al (2008). Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 198: 194 e191-195.
11. Angoa-Perez M, Kane MJ, Briggs DI, Sykes CE, Shah MM, Francescutti DM et al (2012). Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. J Neurochem 121: 974-984.
12. Ansorge MS, Morelli E, Gingrich JA (2008). Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 28: 199-207.
13. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA (2004). Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879-881.
14. Araki KY, Sims JR, Bhide PG (2007). Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre-and postnatal development. Brain Res 1156: 31-45.
15. Arango V, Huang YY, Underwood MD, Mann JJ (2003). Genetics of the serotonergic system in suicidal behavior. J Psychiatr Res 37: 375-386.
16. Armbruster D, Moser DA, Strobel A, Hensch T, Kirschbaum C, Lesch KP et al (2009). Serotonin transporter gene variation and stressful life events impact processing of fear and anxiety. Int J Neuropsychopharmacol 12: 393-401.
17. Atmaca M, Onalan E, Yildirim H, Yuce H, Koc M, Korkmaz S et al (2011). Serotonin transporter gene polymorphism implicates reduced orbito-frontal cortex in obsessive-compulsive disorder. J Anxiety Disord 25: 680-685.
18. Audero E, Mlinar B, Baccini G, Skachokova ZK, Corradetti R, Gross C (2013). Suppression of serotonin neuron firing increases aggression in mice. J Neurosci 33: 8678-8688.
19. Bakker MK, Kolling P, van den Berg PB, de Walle HE, de Jong van den Berg LT (2008). Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol 65: 600-606.
20. Bambico FR, Nguyen NT, Gobbi G (2009). Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. Eur Neuropsychopharmacol 19: 215-228.
21. Bannai M, Fish EW, Faccidomo S, Miczek KA (2007). Anti-aggressive effects of agonists at 5-HT1B receptors in the dorsal raphe nucleus of mice. Psychopharmacology (Berl) 193: 295-304.
22. Baram TZ, Davis EP, Obenaus A, Sandman CA, Small SL, Solodkin A et al (2012). Fragmentation and unpredictability of early-life experience in mental disorders. Am J Psychiatry 169: 907-915.
23. Barratt ES, Felthous AR (2003). Impulsive versus premeditated aggression: implications for mens rea decisions. Behav Sci Law 21: 619-630.
24. Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC et al (2008). Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 105: 1333-1338.
25. Beaver KM, Wright JP, DeLisi M, Walsh A, Vaughn MG, Boisvert D et al (2007). A gene x gene interaction between DRD2 and DRD4 is associated with conduct disorder and antisocial behavior in males. Behav Brain Funct 3: 30.
26. Bedard AC, Schulz KP, Cook EH Jr., Fan J, Clerkin SM, Ivanov I et al (2010). Dopamine transporter gene variation modulates activation of striatum in youth with ADHD. Neuroimage 53: 935-942.
27. Beiderbeck DI, Reber SO, Havasi A, Bredewold R, Veenema AH, Neumann ID (2012). High and abnormal forms of aggression in rats with extremes in trait anxiety - involvement of the dopamine system in the nucleus accumbens. Psychoneuroendocrinology 37: 1969-1980.
28. Beique JC, Campbell B, Perring P, Hamblin MW, Walker P, Mladenovic L et al (2004). Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. J Neurosci 24: 4807-4817.
29. Benekareddy M, Goodfellow NM, Lambe EK, Vaidya VA (2010). Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability. J Neurosci 30: 12138-12150.
30. Benekareddy M, Vadodaria KC, Nair AR, Vaidya VA (2011). Postnatal serotonin type 2 receptor blockade prevents the emergence of anxiety behavior, dysregulated stress-induced immediate early gene responses, and specific transcriptional changes that arise following early life stress. Biol Psychiatry 70: 1024-1032.
31. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A et al (1998). Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice. Mol Pharmacol 53: 649-655.
32. Bennett-Clarke CA, Leslie MJ, Chiaia NL, Rhoades RW (1993). Serotonin 1B receptors in the developing somatosensory and visual cortices are located on thalamocortical axons. Proc Natl Acad Sci USA 90: 153-157.
33. Bennett-Clarke CA, Leslie MJ, Lane RD, Rhoades RW (1994). Effect of serotonin depletion on vibrissa-related patterns of thalamic afferents in the rat's somatosensory cortex. J Neurosci 14: 7594-7607.
34. Berard A, Ramos E, Rey E, Blais L, St-Andre M, Oraichi D (2007). First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol 80: 18-27.
35. Berman ME, McCloskey MS, Fanning JR, Schumacher JA, Coccaro EF (2009). Serotonin augmentation reduces response to attack in aggressive individuals. Psychol Sci 20: 714-720.
36. Bhakta SG, Zhang JP, Malhotra AK (2012). The COMT Met158 allele and violence in schizophrenia: a meta-analysis. Schizophr Res 140: 192-197.
37. Bickerdike MJ, Wright IK, Marsden CA (1993). Social isolation attenuates rat forebrain 5-HT release induced by KCI stimulation and exposure to a novel environment. Behav Pharmacol 4: 231-236.
38. Blokland A, Lieben C, Deutz NE (2002). Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. J Psychopharmacol 16: 39-49.
39. Blue ME, Erzurumlu RS, Jhaveri S (1991). A comparison of pattern formation by thalamocortical and serotonergic afferents in the rat barrel field cortex. Cerebral Cortex 1: 380-389.
40. Bonnin A, Goeden N, Chen K, Wilson ML, King J, Shih JC et al (2011). A transient placental source of serotonin for the fetal forebrain. Nature 472: 347-350.
41. Bonnin A, Peng W, Hewlett W, Levitt P (2006). Expression mapping of 5-HT1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development. Neuroscience 141: 781-794.
42. Bonnin A, Torii M, Wang L, Rakic P, Levitt P (2007). Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nature Neurosci 10: 588-597.
43. Bortolato M, Godar SC, Alzghoul L, Zhang J, Darling RD, Simpson KL et al (2013). Monoamine oxidase A and A/B knockout mice display autistic-like features. Int J Neuropsychopharmacol 16: 869-888.
44. Bradley SL, Dodelzon K, Sandhu HK, Philibert RA (2005). Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription. Am J Med Genet B Neuropsychiatr Genet 136B: 58-61.
45. Brandon CL, Marinelli M, Baker LK, White FJ (2001). Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25: 651-661.
46. Brizer DA (1988). Psychopharmacology and the management of violent patients. Psychiatr Clin North Am 11: 551-568.
47. Brocke B, Armbruster D, Muller J, Hensch T, Jacob CP, Lesch KP et al (2006). Serotonin transporter gene variation impacts innate fear processing: acoustic startle response and emotional startle. Mol Psychiatry 11: 1106-1112.
48. Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV (2001). 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci 21: 3228-3235.
49. Brown GL, Ebert MH, Goyer PF, Jimerson DC, Klein WJ, Bunney WE et al (1982). Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 139: 741-746.
50. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979). Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1: 131-139.
51. Brune CW, Kim SJ, Salt J, Leventhal BL, Lord C, Cook EH Jr. (2006). 5-HTTLPR genotype-specific phenotype in children and adolescents with autism. Am J Psychiatry 163: 2148-2156.
52. Brunner D, Hen R (1997). Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann NY Acad Sci 836: 81-105.
53. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA (1993). Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262: 578-580.
54. Buckholtz JW, Meyer-Lindenberg A (2008). MAOA and the neurogenetic architecture of human aggression. Trends Neurosci 31: 120-129.
55. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Benning SD, Li R et al (2010a). Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci 13: 419-421.
56. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS et al (2010b). Dopaminergic network differences in human impulsivity. Science 329: 532.
57. Burke AR, Forster GL, Novick AM, Roberts CL, Watt MJ (2013). Effects of adolescent social defeat on adult amphetamine-induced locomotion and corticoaccumbal dopamine release in male rats. Neuropharmacology 67: 359-369.
58. Butler PD, Schechter I, Zemon V, Schwartz SG, Greenstein VC, Gordon J et al (2001). Dysfunction of early-stage visual processing in schizophrenia. Am J Psychiatry 158: 1126-1133.
59. Cannon DM, Klaver JM, Klug SA, Carlson PJ, Luckenbaugh DA, Ichise M et al (2013). Gender-specific abnormalities in the serotonin transporter system in panic disorder. Int J Neuropsychopharmacol 16: 733-743.
60. Canteras NS, Graeff FG (2014). Executive and modulatory neural circuits of defensive reactions: implications for panic disorder. Neurosci Biobehav Rev (http://dx.doi.org/10.1016/j.neubiorev.2014.03.020).
61. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S et al (1995). Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268: 1763-1766.
62. Cases O, Vitalis T, Seif I, De Maeyer E, Sotelo C, Gaspar P (1996). Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16: 297-307.
63. Casey BJ, Jones RM, Levita L, Libby V, Pattwell SS, Ruberry EJ et al (2010). The storm and stress of adolescence: insights from human imaging and mouse genetics. Dev Psychobiol 52: 225-235.
64. Casey BJ, Ruberry EJ, Libby V, Glatt CE, Hare T, Soliman F et al (2011). Transitional and translational studies of risk for anxiety. Depress Anxiety 28: 18-28.
65. Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A et al (2003). Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 142: 402-408.
66. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW et al (2002). Role of genotype in the cycle of violence in maltreated children. Science 297: 851-854.
67. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389.
68. Centenaro LA, Vieira K, Zimmermann N, Miczek KA, Lucion AB, de Almeida RM (2008). Social instigation and aggressive behavior in mice: role of 5-HT1A and 5-HT1B receptors in the prefrontal cortex. Psychopharmacology (Berl) 201: 237-248.
69. Challis C, Boulden J, Veerakumar A, Espallergues J, Vassoler FM, Pierce RC et al (2013). Raphe GABAergic neurons mediate the acquisition of avoidance after social defeat. J Neurosci 33: 13978-13988. 13988a.
70. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL et al (2006). Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354: 579-587.
71. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996). Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335: 1010-1015.
72. Chameau P, Inta D, Vitalis T, Monyer H, Wadman WJ, van Hooft JA (2009). The N-terminal region of reelin regulates postnatal dendritic maturation of cortical pyramidal neurons. Proc Natl Acad Sci USA 106: 7227-7232.
73. Charney DS (1998). Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry 59 Suppl 14: 11-14.
74. Chen K, Holschneider DP, Wu W, Rebrin I, Shih JC (2004). A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J Biol Chem 279: 39645-39652.
75. Chengappa KN, Ebeling T, Kang JS, Levine J, Parepally H (1999). Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 60: 477-484.
76. Chiavegatto S, Dawson VL, Mamounas LA, Koliatsos VE, Dawson TM, Nelson RJ (2001). Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc Natl Acad Sci USA 98: 1277-1281.
77. Coccaro EF, Berman ME, Kavoussi RJ, Hauger RL (1996). Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biol Psychiatry 40: 157-164.
78. Coccaro EF, Kavoussi RJ (1997a). Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 54: 1081-1088.
79. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL (1997b). Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry 154: 1430-1435.
80. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB et al (1989). Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46: 587-599.
81. Colzato LS, van den Wildenberg WP, Van der Does AJ, Hommel B (2010). Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity. Neuroscience 170: 782-788.
82. Congdon E, Lesch KP, Canli T (2008). Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity. Am J Med Genet B Neuropsychiatr Genet 147B: 27-32.
83. Cote SM, Boivin M, Nagin DS, Japel C, Xu Q, Zoccolillo M et al (2007). The role of maternal education and nonmaternal care services in the prevention of children's physical aggression problems. Arch Gen Psychiatry 64: 1305-1312.
84. Couppis MH, Kennedy CH (2008). The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice. Psychopharmacology (Berl) 197: 449-456.
85. Crane L, Goddard L, Pring L (2009). Sensory processing in adults with autism spectrum disorders. Autism 13: 215-228.
86. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 68: 1104-1112.
87. Culverhouse RC, Bowes L, Breslau N, Nurnberger JI Jr, Burmeister M, Fergusson DM et al (2013). Protocol for a collaborative meta-analysis of 5-HTTLPR, stress, and depression. BMC Psychiatry 13: 304.
88. da Veiga CP, Miczek KA, Lucion AB, de Almeida RM (2011). Social instigation and aggression in postpartum female rats: role of 5-Ht1A and 5-Ht1B receptors in the dorsal raphe nucleus and prefrontal cortex. Psychopharmacology (Berl) 213: 475-487.
89. Dahl RE, Gunnar MR (2009). Heightened stress responsiveness and emotional reactivity during pubertal maturation: implications for psychopathology. Dev Psychopathol 21: 1-6.
90. Dai JX, Han HL, Tian M, Cao J, Xiu JB, Song NN et al (2008). Enhanced contextual fear memory in central serotonin-deficient mice. Proc Natl Acad Sci USA 105: 11981-11986.
91. Dalley JW, Everitt BJ, Robbins TW (2011). Impulsivity, compulsivity, and top-down cognitive control. Neuron 69: 680-694.
92. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K et al (2007). Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267-1270.
93. Dalley JW, Theobald DE, Pereira EA, Li PM, Robbins TW (2002). Specific abnormalities in serotonin release in the prefrontal cortex of isolation-reared rats measured during behavioural performance of a task assessing visuospatial attention and impulsivity. Psychopharmacology (Berl) 164: 329-340.
94. Damasio H, Grabowski T, Frank R, Galaburda AM, Damasio AR (1994). The return of Phineas Gage: clues about the brain from the skull of a famous patient. Science 264: 1102-1105.
95. Dannlowski U, Ohrmann P, Konrad C, Domschke K, Bauer J, Kugel H et al (2009). Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int J Neuropsychopharmacol 12: 11-22.
96. Davidge KM, Atkinson L, Douglas L, Lee V, Shapiro S, Kennedy JL et al (2004). Association of the serotonin transporter and 5HT1Dbeta receptor genes with extreme, persistent and pervasive aggressive behaviour in children. Psychiatr Genet 14: 143-146.
97. Davidson RJ, Putnam KM, Larson CL (2000). Dysfunction in the neural circuitry of emotion regulation - A possible prelude to violence. Science 289: 591-594.
98. Davis LL, Suris A, Lambert MT, Heimberg C, Petty F (1997). Post-traumatic stress disorder and serotonin: new directions for research and treatment. J Psychiatry Neurosci 22: 318-326.
99. Dawe S, Davis P, Lapworth K, McKetin R (2009). Mechanisms underlying aggressive and hostile behavior in amphetamine users. Curr Opin Psychiatr 22: 269-273.
100. de Almeida RM, Ferrari PF, Parmigiani S, Miczek KA (2005a). Escalated aggressive behavior: dopamine, serotonin and GABA. Eur J Pharmacol 526: 51-64.
101. de Almeida RM, Giovenardi M, da Silva SP, de Oliveira VP, Stein DJ (2005b). Maternal aggression in Wistar rats: effect of 5-HT2A/2C receptor agonist and antagonist microinjected into the dorsal periaqueductal gray matter and medial septum. Braz J Med Biol Res 38: 597-602.
102. de Almeida RM, Giovenardi M, da Silva SP, de Oliveira VP, Stein DJ (2006). The effect of 5-HT(2a/2c) receptor agonist microinjected into central amygdaloid nucleus and median preoptic area on maternal aggressive behavior in rats. Rev Bras Psiquiatr 28: 130-134.
103. De Almeida RM, Lucion AB (1997). 8-OH-DPAT in the median raphe, dorsal periaqueductal gray and corticomedial amygdala nucleus decreases, but in the medial septal area it can increase maternal aggressive behavior in rats. Psychopharmacology (Berl) 134: 392-400.
104. de Boer SF, Koolhaas JM (2005). 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur J Pharmacol 526: 125-139.
105. de Vries NK, van der Veere CN, Reijneveld SA, Bos AF (2013). Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study. PLoS One 8: e64654.
106. DeLeon KR, Grimes JM, Connor DF, Melloni RH Jr. (2002). Adolescent cocaine exposure and offensive aggression: involvement of serotonin neural signaling and innervation in male Syrian hamsters. Behav Brain Res 133: 211-220.
107. Delville Y, Mansour KM, Ferris CF (1996). Testosterone facilitates aggression by modulating vasopressin receptors in the hypothalamus. Physiol Behav 60: 25-29.
108. Dewey D, Cantell M, Crawford SG (2007). Motor and gestural performance in children with autism spectrum disorders, developmental coordination disorder, and/ or attention deficit hyperactivity disorder. J Int Neuropsychol Soc 13: 246-256.
109. Di Chiara G, Camba R, Spano PF (1971). Evidence for inhibition by brain serotonin of mouse killing behaviour in rats. Nature 233: 272-273.
110. Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E et al (2008). Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 66: 695-705.
111. Donaldson ZR, Piel DA, Santos TL, Richardson-Jones J, Leonardo ED, Beck SG et al (2014). Developmental effects of serotonin 1A autoreceptors on anxiety and social behavior. Neuropsychopharmacology 39: 291-302.
112. Doniger GM, Foxe JJ, Murray MM, Higgins BA, Javitt DC (2002). Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia. Arch Gen Psychiatry 59: 1011-1020.
113. Dorevitch A, Katz N, Zemishlany Z, Aizenberg D, Weizman A (1999). Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior. Am J Psychiatry 156: 142-144.
114. Dow-Edwards DL, Busidan Y (2001). Behavioral responses to dopamine agonists in adult rats exposed to cocaine during the preweaning period. Pharmacol Biochem Behav 70: 23-30.
115. El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A et al (2012). Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 69: 706-714.
116. Erzurumlu RS, Gaspar P (2012). Development and critical period plasticity of the barrel cortex. Eur J Neurosci 35: 1540-1553.
117. Esaki T, Cook M, Shimoji K, Murphy DL, Sokoloff L, Holmes A (2005). Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc Natl Acad Sci USA 102: 5582-5587.
118. Espinosa JS, Stryker MP (2012). Development and plasticity of the primary visual cortex. Neuron 75: 230-249.
119. Fairbanks LA, Melega WP, Jorgensen MJ, Kaplan JR, McGuire MT (2001). Social impulsivity inversely associated with CSF 5-HIAA and fluoxetine exposure in vervet monkeys. Neuropsychopharmacology 24: 370-378.
120. Feder A, Skipper J, Blair JR, Buchholz K, Mathew SJ, Schwarz M et al (2011). Tryptophan depletion and emotional processing in healthy volunteers at high risk for depression. Biol Psychiatry 69: 804-807.
121. Fernandez SP, Gaspar P (2012). Investigating anxiety and depressive-like phenotypes in genetic mouse models of serotonin depletion. Neuropharmacology 62: 144-154.
122. Ferrari PF, van Erp AM, Tornatzky W, Miczek KA (2003). Accumbal dopamine and serotonin in anticipation of the next aggressive episode in rats. Eur J Neurosci 17: 371-378.
123. Ferris CF, Melloni RH Jr., Koppel G, Perry KW, Fuller RW, Delville Y (1997). Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J Neurosci 17: 4331-4340.
124. Ferris CF, Potegal M (1988). Vasopressin receptor blockade in the anterior hypothalamus suppresses aggression in hamsters. Physiol Behav 44: 235-239.
125. Fisher HL, Cohen-Woods S, Hosang GM, Uher R, Powell-Smith G, Keers R et al (2012). Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depression. J Affect Disord 136: 189-193.
126. Flint J, Kendler KS (2014). The genetics of major depression. Neuron 81: 484-503.
127. Flory JD, Xu K, New AS, Finch T, Goldman D, Siever LJ (2007). Irritable assault and variation in the COMT gene. Psychiatr Genet 17: 344-346.
128. Franklin TB, Linder N, Russig H, Thony B, Mansuy IM (2011). Influence of early stress on social abilities and serotonergic functions across generations in mice. PLoS One 6: e21842.
129. Frodl T, Koutsouleris N, Bottlender R, Born C, Jager M, Morgenthaler M et al (2008). Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry 13: 1093-1101.
130. Fulford AJ, Marsden CA (1998). Conditioned release of 5-hydroxytryptamine in vivo in the nucleus accumbens following isolation-rearing in the rat. Neuroscience 83: 481-487.
131. Fulford AJ, Marsden CA (2007). An intact dopaminergic system is required for context-conditioned release of 5-HT in the nucleus accumbens of postweaning isolation-reared rats. Neuroscience 149: 392-400.
132. Fuller RW, Wong DT (1990). Serotonin uptake and serotonin uptake inhibition. Ann N Y Acad Sci 600: 68-78.
133. Furmark T, Tillfors M, Garpenstrand H, Marteinsdottir I, Langstrom B, Oreland L et al (2004). Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett 362: 189-192.
134. Gaspar P, Cases O, Maroteaux L (2003). The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4: 1002-1012.
135. Giorgi O, De Montis G, Porceddu ML, Mele S, Calderini G, Toffano G et al (1987). Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum. Brain Res 432: 283-290.
136. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612.
137. Godar SC, Bortolato M, Frau R, Dousti M, Chen K, Shih JC (2010). Maladaptive defensive behaviours in monoamine oxidase A-deficient mice. Int J Neuropsychopharmacol 14: 1195-1207.
138. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D et al (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95: 9991-9996.
139. Gollan JK, Lee R, Coccaro EF (2005). Developmental psychopathology and neurobiology of aggression. Dev Psychopathol 17: 1151-1171.
140. Goyer PF, Andreason PJ, Semple WE, Clayton AH, King AC, Compton-Toth BA et al (1994). Positron-emission tomography and personality disorders. Neuropsychopharmacology 10: 21-28.
141. Grabe HJ, Schwahn C, Mahler J, Schulz A, Spitzer C, Fenske K et al (2012). Moderation of adult depression by the serotonin transporter promoter variant (5-HTTLPR), childhood abuse and adult traumatic events in a general population sample. Am J Med Genet B Neuropsychiatr Genet 159B: 298-309.
142. Grafman J, Schwab K, Warden D, Pridgen A, Brown HR, Salazar AM (1996). Frontal lobe injuries, violence, and aggression: a report of the Vietnam Head Injury Study. Neurology 46: 1231-1238.
143. Gregg TR, Siegel A (2001). Brain structures and neurotransmitters regulating aggression in cats: implications for human aggression. Progress Neuropsychopharmacol Biol Psychiatry 25: 91-140.
144. Griebel G, Perrault G, Sanger DJ (1997). A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety. Neuropharmacology 36: 793-802.
145. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L et al (2002). Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416: 396-400.
146. Grzeskowiak LE, Gilbert AL, Morrison JL (2012). Neonatal outcomes after lategestation exposure to selective serotonin reuptake inhibitors. J Clin Psychopharmacol 32: 615-621.
147. Gu Y, Yun L, Tian Y, Hu Z (2009). Association between COMT gene and Chinese male schizophrenic patients with violent behavior. Med Sci Monit 15: CR484-CR489.
148. Guo G, Roettger ME, Shih JC (2007). Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults. Hum Genet 121: 125-136.
149. Gutknecht L, Jacob C, Strobel A, Kriegebaum C, Muller J, Zeng Y et al (2007). Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. Int J Neuropsychopharmacol 10: 309-320.
150. Hahn A, Stein P, Windischberger C, Weissenbacher A, Spindelegger C, Moser E et al (2011). Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder. NeuroImage 56: 881-889.
151. Hall FS, Wilkinson LS, Humby T, Inglis W, Kendall DA, Marsden CA et al (1998). Isolation rearing in rats: pre-and postsynaptic changes in striatal dopaminergic systems. Pharmacol Biochem Behav 59: 859-872.
152. Haller J (2013). The neurobiology of abnormal manifestations of aggression - a review of hypothalamic mechanisms in cats, rodents, and humans. Brain Res Bull 93: 97-109.
153. Han DH, Park DB, Na C, Kee BS, Lee YS (2004). Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes. Psychiatry Res 129: 29-37.
154. Hanley GE, Brain U, Oberlander TF (2013). Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect. Early Hum Dev 89: 519-524.
155. Hansen HH, Sanchez C, Meier E (1997). Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression? J Pharmacol Exp Ther 283: 1333-1341.
156. Hansson SR, Mezey E, Hoffman BJ (1998). Serotonin transporter messenger RNA in the developing rat brain: early expression in serotonergic neurons and transient expression in non-serotonergic neurons. Neuroscience 83: 1185-1201.
157. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D et al (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science 297: 400-403.
158. Harrison RJ, Connor DF, Nowak C, Melloni RH Jr (2000). Chronic low-dose cocaine treatment during adolescence facilitates aggression in hamsters. Physiol Behav 69: 555-562.
159. Hartley CA, McKenna MC, Salman R, Holmes A, Casey BJ, Phelps EA et al (2012). Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory. Proc Natl Acad Sci USA 109: 5493-5498.
160. Haydon PG, McCobb DP, Kater SB (1984). Serotonin selectively inhibits growth cone motility and synaptogenesis of specific identified neurons. Science 226: 561-564.
161. Haydon PG, McCobb DP, Kater SB (1987). The regulation of neurite outgrowth, growth cone motility, and electrical synaptogenesis by serotonin. J Neurobiol 18: 197-215.
162. Hazlett EA, New AS, Newmark R, Haznedar MM, Lo JN, Speiser LJ et al (2005). Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry 58: 614-623.
163. Heidbreder CA, Weiss IC, Domeney AM, Pryce C, Homberg J, Hedou G et al (2000). Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome. Neuroscience 100: 749-768.
164. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al (1996). Allelic variation of human serotonin transporter gene expression. J Neurochem 66: 2621-2624.
165. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D et al (2005). Amygdalaprefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 8: 20-21.
166. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH et al (1998). Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA 95: 15049-15054.
167. Hellendall RP, Schambra UB, Liu JP, Lauder JM (1993). Prenatal expression of 5-HT1C and 5-HT2 receptors in the rat central nervous system. Exp Neurol 120: 186-201.
168. Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D (2003). Placental passage of antidepressant medications. Am J Psychiatry 160: 993-996.
169. Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B et al (2003). Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 37: 233-247.
170. Hensch TK (2004). Critical period regulation. Annu Rev Neurosci 27: 549-579.
171. Hensch TK (2005). Critical period plasticity in local cortical circuits. Nat Rev Neurosci 6: 877-888.
172. Hess WR (1928). Stammganglien-Reizversuche. Berichte der gesamten. Physiologie 42: 554-555.
173. Higley JD, King ST Jr., Hasert MF, Champoux M, Suomi SJ, Linnoila M (1996a). Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in rhesus macaque females. Neuropsychopharmacology 14: 67-76.
174. Higley JD, Mehlman PT, Higley SB, Fernald B, Vickers J, Lindell SG et al (1996b). Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Arch Gen Psychiatry 53: 537-543.
175. Higley JD, Mehlman PT, Poland RE, Taub DM, Vickers J, Suomi SJ et al (1996c). CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biol Psychiatry 40: 1067-1082.
176. Higley JD, Mehlman PT, Taub DM, Higley SB, Suomi SJ, Vickers JH et al (1992). Cerebrospinal fluid monoamine and adrenal correlates of aggression in freeranging rhesus monkeys. Arch Gen Psychiatry 49: 436-441.
177. Hirvonen J, van Erp TG, Huttunen J, Aalto S, Nagren K, Huttunen M et al (2005). Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry 62: 371-378.
178. Hodge GK, Butcher LL (1974). 5-Hydroxytryptamine correlates of isolation-induced aggression in mice. Eur J Pharmacol 28: 326-337.
179. Hoffman RE, Dobscha SK (1989). Cortical pruning and the development of schizophrenia: a computer model. Schizophr Bull 15: 477-490.
180. Hoftman GD, Lewis DA (2011). Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophr Bull 37: 493-503.
181. Hohmann CF, Hamon R, Batshaw ML, Coyle JT (1988). Transient postnatal elevation of serotonin levels in mouse neocortex. Brain Res 471: 163-166.
182. Holmes A, Murphy DL, Crawley JN (2002). Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 161: 160-167.
183. Hong JP, Lee JS, Chung S, Jung J, Yoo HK, Chang SM et al (2008). New functional single nucleotide polymorphism (Ala72Ser) in the COMT gene is associated with aggressive behavior in male schizophrenia. Am J Med Genet B Neuropsychiatr Genet 147B: 658-660.
184. Inan M, Crair MC (2007). Development of cortical maps: perspectives from the barrel cortex. Neuroscientist 13: 49-61.
185. Iniguez SD, Alcantara LF, Warren BL, Riggs LM, Parise EM, Vialou V et al (2014). Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood. J Neurosci 34: 1007-1021.
186. Iniguez SD, Warren BL, Bolanos-Guzman CA (2010). Short-and long-term functional consequences of fluoxetine exposure during adolescence in male rats. Biol Psychiatry 67: 1057-1066.
187. Jackson D, Burns R, Trksak G, Simeone B, DeLeon KR, Connor DF et al (2005). Anterior hypothalamic vasopressin modulates the aggression-stimulating effects of adolescent cocaine exposure in Syrian hamsters. Neuroscience 133: 635-646.
188. Jennings KA, Loder MK, Sheward WJ, Pei Q, Deacon RM, Benson MA et al (2006). Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J Neurosci 26: 8955-8964.
189. Jiang X, Wang J, Luo T, Li Q (2009). Impaired hypothalamic-pituitary-adrenal axis and its feedback regulation in serotonin transporter knockout mice. Psychoneuroendocrinology 34: 317-331.
190. Jones GH, Hernandez TD, Kendall DA, Marsden CA, Robbins TW (1992). Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry. Pharmacol Biochem Behav 43: 17-35.
191. Jung AB, Bennett JP Jr. (1996). Development of striatal dopaminergic function. III: Pre-and postnatal development of striatal and cortical mRNAs for the neurotrophin receptors trkBTK+ and trkC and their regulation by synaptic dopamine. Brain Res Dev Brain Res 94: 133-143.
192. Kalinichev M, Easterling KW, Plotsky PM, Holtzman SG (2002). Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long-Evans rats. Pharmacol Biochem Behav 73: 131-140.
193. Kalsbeek A, Voorn P, Buijs RM, Pool CW, Uylings HB (1988). Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neurol 269: 58-72.
194. Kalueff AV, Fox MA, Gallagher PS, Murphy DL (2007). Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav 6: 389-400.
195. Karg K, Burmeister M, Shedden K, Sen S (2011). The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 68: 444-454.
196. Karpova NN, Lindholm J, Pruunsild P, Timmusk T, Castren E (2009). Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. Eur Neuropsychopharmacol 19: 97-108.
197. Kehne JH, Baron BM, Carr AA, Chaney SF, Elands J, Feldman DJ et al (1996). Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277: 968-981.
198. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ (1992). Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry 49: 716-722.
199. Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M et al (2012). Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 344: d8012.
200. Killackey HP (1973). Anatomical evidence for cortical subdivisions based on vertically discrete thalamic projections from the ventral posterior nucleus to cortical barrels in the rat. Brain Res 51: 326-331.
201. Kim DK, Tolliver TJ, Huang SJ, Martin BJ, Andrews AM, Wichems C et al (2005). Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49: 798-810.
202. Kinney GG, Vogel GW, Feng P (1997). Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression. Brain Res 756: 68-75.
203. Kiyasova V, Fernandez SP, Laine J, Stankovski L, Muzerelle A, Doly S et al (2011a). A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei. J Neurosci 31: 2756-2768.
204. Kiyasova V, Gaspar P (2011b). Development of raphe serotonin neurons from specification to guidance. Eur J Neurosci 34: 1553-1562.
205. Knudsen EI (2004). Sensitive periods in the development of the brain and behavior. J Cogn Neurosci 16: 1412-1425.
206. Kobiella A, Reimold M, Ulshofer DE, Ikonomidou VN, Vollmert C, Vollstadt-Klein S et al (2011). How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure. Transl Psychiatry 1: e37.
207. Koe BK, Weissman A (1966). p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 154: 499-516.
208. Koh KB, Choi EH, Lee YJ, Han M, Choi SS, Kim SW et al (2012). The relation of serotonin-related gene and COMT gene polymorphisms with criminal behavior in schizophrenic disorder. J Clin Psychiatry 73: 159-163.
209. Koolhaas JM, Everts H, de Ruiter AJ, de Boer SF, Bohus B (1998). Coping with stress in rats and mice: differential peptidergic modulation of the amygdalalateral septum complex. Prog Brain Res 119: 437-448.
210. Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, Gritsenko I et al (1999). Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet 88: 628-633.
211. Kovacic Z, Henigsberg N, Pivac N, Nedic G, Borovecki A (2008). Platelet serotonin concentration and suicidal behavior in combat related posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 32: 544-551.
212. Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB (2006). Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 63: 622-629.
213. Kruesi MJ, Hibbs ED, Zahn TP, Keysor CS, Hamburger SD, Bartko JJ et al (1992). A 2-year prospective follow-up study of children and adolescents with disruptive behavior disorders. Prediction by cerebrospinal fluid 5-hydroxyindoleacetic acid, homovanillic acid, and autonomic measures? Arch Gen Psychiatry 49: 429-435.
214. Kruesi MJ, Rapoport JL, Hamburger S, Hibbs E, Potter WZ, Lenane M et al (1990). Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch Gen Psychiatry 47: 419-426.
215. Kruk MR, Vanderpoel AM, Devosfrerichs TP (1979). Induction of aggressivebehavior by electrical-stimulation in the hypothalamus of male-rats. Behaviour 70: 292-322.
216. Kruk MR, Vanderpoel AM, Meelis W, Hermans J, Mostert PG, Mos J et al (1983). Discriminant-analysis of the localization of aggression-inducing electrode placements in the hypothalamus of male-rats. Brain Res 260: 61-79.
217. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J (1998). Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 155: 835-837.
218. Lambe EK, Krimer LS, Goldman-Rakic PS (2000). Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey. J Neurosci 20: 8780-8787.
219. Lammers JH, Kruk MR, Meelis W, van der Poel AM (1988). Hypothalamic substrates for brain stimulation-induced attack, teeth-chattering and social grooming in the rat. Brain Res 449: 311-327.
220. Lauder JM (1990). Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Ann N Y Acad Sci 600: 297-313.
221. Lauder JM, Bloom FE (1974). Ontogeny of monoamine neurons in the locus coeruleus, Raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J Comp Neurol 155: 469-481.
222. Laurent A, Goaillard JM, Cases O, Lebrand C, Gaspar P, Ropert N (2002). Activitydependent presynaptic effect of serotonin 1B receptors on the somatosensory thalamocortical transmission in neonatal mice. J Neurosci 22: 886-900.
223. Lebrand C, Cases O, Adelbrecht C, Doye A, Alvarez C, El Mestikawy S et al (1996). Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17: 823-835.
224. Lebrand C, Cases O, Wehrle R, Blakely RD, Edwards RH, Gaspar P (1998). Transient developmental expression of monoamine transporters in the rodent forebrain. J Comp Neurol 401: 506-524.
225. Lebrand C, Gaspar P, Nicolas D, Hornung JP (2006). Transitory uptake of serotonin in the developing sensory pathways of the common marmoset. J Comp Neurol 499: 677-689.
226. Lee TM, Chan SC, Raine A (2008). Strong limbic and weak frontal activation to aggressive stimuli in spouse abusers. Mol Psychiatry 13: 655-656.
227. Lehmann J, Pryce CR, Bettschen D, Feldon J (1999). The maternal separation paradigm and adult emotionality and cognition in male and female Wistar rats. Pharmacol Biochem Behav 64: 705-715.
228. Lemogne C, Gorwood P, Boni C, Pessiglione M, Lehericy S, Fossati P (2011). Cognitive appraisal and life stress moderate the effects of the 5-HTTLPR polymorphism on amygdala reactivity. Hum Brain Mapp 32: 1856-1867.
229. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD et al (2003). Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23: 8788-8799.
230. Lenox RH, Newhouse PA, Creelman WL, Whitaker TM (1992). Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. J Clin Psychiatry 53: 47-52.
231. Lerner Y, Lwow E, Levitin A, Belmaker RH (1979). Acute high-dose parenteral haloperidol treatment of psychosis. Am J Psychiatry 136: 1061-1064.
232. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531.
233. Levallois C, Valence C, Baldet P, Privat A (1997). Morphological and morphometric analysis of serotonin-containing neurons in primary dissociated cultures of human rhombencephalon: a study of development. Brain Res Dev Brain Res 99: 243-252.
234. Leventopoulos M, Russig H, Feldon J, Pryce CR, Opacka-Juffry J (2009). Early deprivation leads to long-term reductions in motivation for reward and 5-HT1A binding and both effects are reversed by fluoxetine. Neuropharmacology 56: 692-701.
235. Li H, Fertuzinhos S, Mohns E, Hnasko TS, Verhage M, Edwards R et al (2013). Laminar and columnar development of barrel cortex relies on thalamocortical neurotransmission. Neuron 79: 970-986.
236. Lidov HG, Molliver ME (1982a). An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res Bull 8: 389-430.
237. Lidov HG, Molliver ME (1982b). Immunohistochemical study of the development of serotonergic neurons in the rat CNS. Brain Res Bull 9: 559-604.
238. Lim JE, Papp A, Pinsonneault J, Sadee W, Saffen D (2006). Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Mol Psychiatry 11: 649-662.
239. Lin D, Boyle MP, Dollar P, Lee H, Lein ES, Perona P et al (2011). Functional identifi cation of an aggression locus in the mouse hypothalamus. Nature 470: 221-226.
240. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK (1983). Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33: 2609-2614.
241. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH et al (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54: 960-971.
242. Liu Z, Zhou J, Li Y, Hu F, Lu Y, Ma M et al (2014). Dorsal Raphe neurons signal reward through 5-HT and glutamate. Neuron 81: 1360-1374.
243. Lo Iacono L, Gross C (2008). Alpha-Ca2+/calmodulin-dependent protein kinase II contributes to the developmental programming of anxiety in serotonin receptor 1A knock-out mice. J Neurosci 28: 6250-6257.
244. Loughhead AM, Fisher AD, Newport DJ, Ritchie JC, Owens MJ, DeVane CL et al (2006). Antidepressants in amniotic fluid: another route of fetal exposure. Am J Psychiatry 163: 145-147.
245. Lukkes JL, Mokin MV, Scholl JL, Forster GL (2009). Adult rats exposed to early-life social isolation exhibit increased anxiety and conditioned fear behavior, and altered hormonal stress responses. Horm Behav 55: 248-256.
246. Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10: 434-445.
247. Maciag D, Simpson KL, Coppinger D, Lu Y, Wang Y, Lin RC et al (2006). Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 31: 47-57.
248. Maeda H, Maki S (1986). Dopaminergic facilitation of recovery from amygdaloid lesions which affect hypothalamic defensive attack in cats. Brain Res 363: 135-140.
249. Maeda H, Sato T, Maki S (1985). Effects of dopamine agonists on hypothalamic defensive attack in cats. Physiol Behav 35: 89-92.
250. Mague SD, Andersen SL, Carlezon WA Jr. (2005). Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. Biol Psychiatry 57: 120-125.
251. Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L et al (1998). Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44: 1090-1098.
252. Malm H, Artama M, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomaki S et al (2012). Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI). BMC Psychiatry 12: 217.
253. Manuck SB, Flory JD, McCaffery JM, Matthews KA, Mann JJ, Muldoon MF (1998). Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology 19: 287-299.
254. Marmolejo N, Paez J, Levitt JB, Jones LB (2012). Early postnatal lesion of the medial dorsal nucleus leads to loss of dendrites and spines in adult prefrontal cortex. Dev Neurosci 34: 463-476.
255. Maron E, Kuikka JT, Shlik J, Vasar V, Vanninen E, Tiihonen J (2004). Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res 132: 173-181.
256. Martin SP, Smith EO, Byrd LD (1990). Effects of dominance rank on d-amphetamine-induced increases in aggression. Pharmacol Biochem Behav 37: 493-496.
257. Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM (2004). Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 140: 169-181.
258. McCarthy D, Lueras P, Bhide PG (2007). Elevated dopamine levels during gestation produce region-specific decreases in neurogenesis and subtle deficits in neuronal numbers. Brain Res 1182: 11-25.
259. McCutcheon JE, Conrad KL, Carr SB, Ford KA, McGehee DS, Marinelli M (2012). Dopamine neurons in the ventral tegmental area fire faster in adolescent rats than in adults. J Neurophysiol 108: 1620-1630.
260. McCutcheon JE, Marinelli M (2009). Age matters. Eur J Neurosci 29: 997-1014.
261. Mehlman PT, Higley JD, Faucher I, Lilly AA, Taub DM, Vickers J et al (1994). Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in nonhuman primates. Am J Psychiatry 151: 1485-1491.
262. Meloy JR (2006). Empirical basis and forensic application of affective and predatory violence. Aust N Z J Psychiatry 40: 539-547.
263. Miczek KA, Maxson SC, Fish EW, Faccidomo S (2001). Aggressive behavioral phenotypes in mice. Behav Brain Res 125: 167-181.
264. Miczek KA, Mos J, Olivier B (1989). Brain 5-HT and inhibition of aggressive behavior in animals: 5-HIAA and receptor subtypes. Psychopharmacol Bull 25: 399-403.
265. Mik HM, Ehtesham S, Baldassarra L, De Luca V, Davidge K, Bender D et al (2007). Serotonin system genes and childhood-onset aggression. Psychiatr Genet 17: 11.
266. Misri S, Reebye P, Kendrick K, Carter D, Ryan D, Grunau RE et al (2006). Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry 163: 1026-1032.
267. Moffitt TE, Caspi A, Harrington H, Milne BJ, Melchior M, Goldberg D et al (2007). Generalized anxiety disorder and depression: childhood risk factors in a birth cohort followed to age 32. Psychol Med 37: 441-452.
268. Moll GH, Mehnert C, Wicker M, Bock N, Rothenberger A, Ruther E et al (2000). Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood. Brain Res Dev Brain Res 119: 251-257.
269. Mooney RD, Crnko-Hoppenjans TA, Ke M, Bennett-Clarke CA, Lane RD, Chiaia NL et al (1998). Augmentation of serotonin in the developing superior colliculus alters the normal development of the uncrossed retinotectal projection. J Comp Neurol 393: 84-92.
270. Mooney RD, Shi MY, Rhoades RW (1994). Modulation of retinotectal transmission by presynaptic 5-HT1B receptors in the superior colliculus of the adult hamster. J Neurophysiol 72: 3-13.
271. Morelli E, Moore H, Rebello TJ, Gray N, Steele K, Esposito E et al (2011). Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction. J Neurosci 31: 15742-15750.
272. Morford LL, Inman-Wood SL, Gudelsky GA, Williams MT, Vorhees CV (2002). Impaired spatial and sequential learning in rats treated neonatally with D-fenfluramine. Eur J Neurosci 16: 491-500.
273. Morrison TR, Melloni RH Jr. (2014). The role of serotonin, vasopressin, and serotonin/vasopressin interactions in aggressive behavior. Curr Top Behav Neurosci 17: 189-228.
274. Mosienko V, Bert B, Beis D, Matthes S, Fink H, Bader M et al (2012). Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin. Transl Psychiatry 2: e122.
275. Moy SS, Nadler JJ, Young NB, Nonneman RJ, Grossman AW, Murphy DL et al (2009). Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav 8: 129-142.
276. Muller JM, Morelli E, Ansorge M, Gingrich JA (2011). Serotonin transporter deficient mice are vulnerable to escape deficits following inescapable shocks. Genes Brain Behav 10: 166-175.
277. Munafo MR, Durrant C, Lewis G, Flint J (2009). Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry 65: 211-219.
278. Murphy SE, Norbury R, Godlewska BR, Cowen PJ, Mannie ZM, Harmer CJ et al (2013). The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: a meta-analysis. Mol Psychiatry 18: 512-520.
279. Murthy NV, Selvaraj S, Cowen PJ, Bhagwagar Z, Riedel WJ, Peers P et al (2010). Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain. Neuroimage 52: 50-54.
280. Nagin D, Tremblay RE (1999). Trajectories of boys' physical aggression, opposition, and hyperactivity on the path to physically violent and nonviolent juvenile delinquency. Child Dev 70: 1181-1196.
281. Narayan VM, Narr KL, Kumari V, Woods RP, Thompson PM, Toga AW et al (2007). Regional cortical thinning in subjects with violent antisocial personality disorder or schizophrenia. Am J Psychiatry 164: 1418-1427.
282. Narboux-Neme N, Pavone LM, Avallone L, Zhuang X, Gaspar P (2008). Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRIs). Neuropharmacology 55: 994-1005.
283. Narboux-Neme N, Sagne C, Doly S, Diaz SL, Martin CB, Angenard G et al (2011). Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences. Neuropsychopharmacology 36: 2538-2550.
284. New AS, Hazlett EA, Buchsbaum MS, Goodman M, Mitelman SA, Newmark R et al (2007). Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology 32: 1629-1640.
285. Noisin EL, Thomas WE (1988). Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex. Brain Res 469: 241-252.
286. Norcross M, Mathur P, Enoch AJ, Karlsson RM, Brigman JL, Cameron HA et al (2008). Effects of adolescent fluoxetine treatment on fear-, anxiety-or stressrelated behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology (Berl) 200: 413-424.
287. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JG et al (1997). Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336: 258-262.
288. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S et al (2002). Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 159: 1889-1895.
289. Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJ, Simpson EM (2008). Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Mol Psychiatry 13: 65-73.
290. Oberlander TF, Papsdorf M, Brain UM, Misri S, Ross C, Grunau RE (2010). Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med 164: 444-451.
291. Oberlander TF, Reebye P, Misri S, Papsdorf M, Kim J, Grunau RE (2007). Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med 161: 22-29.
292. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C (2006). Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 63: 898-906.
293. Ohta K, Miki T, Warita K, Suzuki S, Kusaka T, Yakura T et al (2014). Prolonged maternal separation disturbs the serotonergic system during early brain development. Int J Dev Neurosci 33: 15-21.
294. Olivier B, Mos J, van Oorschot R, Hen R (1995). Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 28 Suppl 2: 80-90.
295. Olson L, Seiger A (1972). Early prenatal ontogeny of central monoamine neurons in the rat: fluorescence histochemical observations. Z Anat Entwickl 137: 301-316.
296. Oquendo MA, Hastings RS, Huang YY, Simpson N, Ogden RT, Hu XZ et al (2007). Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Arch Gen Psychiatry 64: 201-208.
297. Pacheco J, Beevers CG, Benavides C, McGeary J, Stice E, Schnyer DM (2009). Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism. J Neurosci 29: 6229-6233.
298. Page DT, Kuti OJ, Prestia C, Sur M (2009). Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior. Proc Natl Acad Sci USA 106: 1989-1994.
299. Pardini M, Krueger F, Hodgkinson C, Raymont V, Ferrier C, Goldman D et al (2011). Prefrontal cortex lesions and MAO-A modulate aggression in penetrating traumatic brain injury. Neurology 76: 1038-1045.
300. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M (1998). Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci USA 95: 10734-10739.
301. Parsey RV, Hastings RS, Oquendo MA, Hu X, Goldman D, Huang YY et al (2006). Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 163: 48-51.
302. Parsey RV, Oquendo MA, Simpson NR, Ogden RT, Van Heertum R, Arango V et al (2002). Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 954: 173-182.
303. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S et al (1993). Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269: 2246-2248.
304. Patkar AA, Berrettini WH, Hoehe M, Thornton CC, Gottheil E, Hill K et al (2002). Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals. Psychiatry Res 110: 103-115.
305. Pavlov KA, Chistiakov DA, Chekhonin VP (2012). Genetic determinants of aggression and impulsivity in humans. J Appl Genet 53: 61-82.
306. Pedersen LH, Henriksen TB, Vestergaard M, Olsen J, Bech BH (2009). Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 339: b3569.
307. Perez-Rodriguez MM, Weinstein S, New AS, Bevilacqua L, Yuan Q, Zhou Z et al (2010). Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls. J Psychiatric Res 44: 1075-1081.
308. Persico AM, Mengual E, Moessner R, Hall FS, Revay RS, Sora I et al (2001). Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci 21: 6862-6873.
309. Petersen CC (2007). The functional organization of the barrel cortex. Neuron 56: 339-355.
310. Peyrot WJ, Middeldorp CM, Jansen R, Smit JH, de Geus EJ, Hottenga JJ et al (2013). Strong effects of environmental factors on prevalence and course of major depressive disorder are not moderated by 5-HTTLPR polymorphisms in a large Dutch sample. J Affect Disord 146: 91-99.
311. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS et al (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 8: 828-834.
312. Philibert RA, Sandhu H, Hollenbeck N, Gunter T, Adams W, Madan A (2008). The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet 147B: 543-549.
313. Piek JP, Dyck MJ (2004). Sensory-motor deficits in children with developmental coordination disorder, attention deficit hyperactivity disorder and autistic disorder. Hum Mov Sci 23: 475-488.
314. Pietrek C, Elbert T, Weierstall R, Muller O, Rockstroh B (2013). Childhood adversities in relation to psychiatric disorders. Psychiatry Res 206: 103-110.
315. Popa D, Lena C, Alexandre C, Adrien J (2008). Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 28: 3546-3554.
316. Popolo M, McCarthy DM, Bhide PG (2004). Influence of dopamine on precursor cell proliferation and differentiation in the embryonic mouse telencephalon. Dev Neurosci 26: 229-244.
317. Potegal M, Gibbons JL, Glusman M (1980). Inhibition of muricide by septal stimulation in rats. Physiol Behav 5: 863-867.
318. Prater KE, Hosanagar A, Klumpp H, Angstadt M, Phan KL (2013). Aberrant amygdala-frontal cortex connectivity during perception of fearful faces and at rest in generalized social anxiety disorder. Depress Anxiety 30: 234-241.
319. Preuss UW, Soyka M, Bahlmann M, Wenzel K, Behrens S, de Jonge S et al (2000). Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity. Psychiatry Res 96: 51-61.
320. Quinn JJ, Skipper RA, Claflin DI (2013). Infant stress exposure produces persistent enhancement of fear learning across development. Dev Psychobiol 56: 1008-1016.
321. Raftogianni A, Diamantopoulou A, Alikaridis F, Stamatakis A, Stylianopoulou F (2012). Effects of interaction of an early experience of reward through maternal contact or its denial with social stress during adolescence on the serotonergic system and the stress responsiveness of adult female rats. Neuroscience 209: 84-96.
322. Rahdar A, Galvan A (2014). The cognitive and neurobiological effects of daily stress in adolescents. Neuroimage 92C: 267-273.
323. Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C (2013). Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 346: f2059.
324. Raine A, Lencz T, Bihrle S, LaCasse L, Colletti P (2000). Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch Gen Psychiatry 57: 119-127.
325. Raine A, Meloy JR, Bihrle S, Stoddard J, LaCasse L, Buchsbaum MS (1998). Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers. Behav Sci Law 16: 319-332.
326. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M et al (1998). Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 95: 14476-14481.
327. Rampono J, Proud S, Hackett LP, Kristensen JH, Ilett KF (2004). A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int J Neuropsychopharmacol 7: 329-334.
328. Rebello TJ, Yu Q, Goodfellow NM, Caffrey Cagliostro MK, Teissier A, Morelli E et al (2014). Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. J Neurosci 34: 12379-12393.
329. Reese BE, Cowey A (1983). Projection lines and the ipsilateral retino-geniculate pathway in the hooded rat. Neuroscience 10: 1233-1247.
330. Rentesi G, Antoniou K, Marselos M, Syrrou M, Papadopoulou-Daifoti Z, Konstandi M (2013). Early maternal deprivation-induced modifications in the neurobiological, neurochemical and behavioral profile of adult rats. Behav Brain Res 244: 29-37.
331. Reuter M, Kuepper Y, Hennig J (2007). Association between a polymorphism in the promoter region of the TPH2 gene and the personality trait of harm avoidance. Int J Neuropsychopharmacol 10: 401-404.
332. Rhoades RW, Bennett-Clarke CA, Shi MY, Mooney RD (1994). Effects of 5-HT on thalamocortical synaptic transmission in the developing rat. J Neurophysiol 72: 2438-2450.
333. Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A et al (2011). Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J Neurosci 31: 6008-6018.
334. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J et al (2009). Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 301: 2462-2471.
335. Rocca P, Marchiaro L, Cocuzza E, Bogetto F (2002). Treatment of borderline personality disorder with risperidone. J Clin Psychiatry 63: 241-244.
336. Rodriguez-Arias M, Minarro J, Aguilar MA, Pinazo J, Simon VM (1998). Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice. Eur Neuropsychopharmacol 8: 95-103.
337. Rodriguiz RM, Chu R, Caron MG, Wetsel WC (2004). Aberrant responses in social interaction of dopamine transporter knockout mice. Behavl Brain Res 148: 185-198.
338. Roeling TA, Veening JG, Kruk MR, Peters JP, Vermelis ME, Nieuwenhuys R (1994). Efferent connections of the hypothalamic 'aggression area' in the rat. Neuroscience 59: 1001-1024.
339. Rogers SJ, Ozonoff S (2005). Annotation: what do we know about sensory dysfunction in autism? A critical review of the empirical evidence. J Child Psychol Psychiatry 46: 1255-1268.
340. Roiser JP, de Martino B, Tan GC, Kumaran D, Seymour B, Wood NW et al (2009). A genetically mediated bias in decision making driven by failure of amygdala control. J Neurosci 29: 5985-5991.
341. Rosell DR, Thompson JL, Slifstein M, Xu X, Frankle WG, New AS et al (2010). Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry 67: 1154-1162.
342. Rumajogee P, Verge D, Hanoun N, Brisorgueil MJ, Hen R, Lesch KP et al (2004). Adaption of the serotoninergic neuronal phenotype in the absence of 5-HT autoreceptors or the 5-HT transporter: involvement of BDNF and cAMP. Eur J Neurosci 19: 937-944.
343. Sabol SZ, Hu S, Hamer D (1998). A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103: 273-279.
344. Salichon N, Gaspar P, Upton AL, Picaud S, Hanoun N, Hamon M et al (2001). Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci 21: 884-896.
345. Salisbury AL, Wisner KL, Pearlstein T, Battle CL, Stroud L, Lester BM (2011). Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress Anxiety 28: 1008-1019.
346. Sarkar A, Chachra P, Vaidya VA (2013). Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT receptor blockade and mimicked by postnatal 5-HT receptor stimulation. Biol Psychiatry (in press).
347. Saudou F, Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L et al (1994). Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265: 1875-1878.
348. Scharinger C, Rabl U, Sitte HH, Pezawas L (2010). Imaging genetics of mood disorders. Neuroimage 53: 810-821.
349. Schinka JA, Busch RM, Robichaux-Keene N (2004). A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry 9: 197-202.
350. Schluter T, Winz O, Henkel K, Prinz S, Rademacher L, Schmaljohann J et al (2013). The impact of dopamine on aggression: an [18F]-FDOPA PET Study in healthy males. J Neurosci 33: 16889-16896.
351. Schmidt LG, Sander T, Kuhn S, Smolka M, Rommelspacher H, Samochowiec J et al (2000). Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressive alcoholics. J Neural Transm 107: 681-689.
352. Schmitz A, Kirsch P, Reuter M, Alexander N, Kozyra E, Kuepper Y et al (2009). The 5-HT1A C(-1019)G polymorphism, personality and electrodermal reactivity in a reward/punishment paradigm. Int J Neuropsychopharmacol 12: 383-392.
353. Schulz SC, Camlin KL, Berry SA, Jesberger JA (1999). Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry 46: 1429-1435.
354. Schwartzer JJ, Melloni RH Jr. (2010). Anterior hypothalamic dopamine D2 receptors modulate adolescent anabolic/androgenic steroid-induced offensive aggression in the Syrian hamster. Behav Pharmacol 21: 314-322.
355. Scott AL, Bortolato M, Chen K, Shih JC (2008). Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport 19: 739-743.
356. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M et al (2006). Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 63: 90-100.
357. Selemon LD (2013). A role for synaptic plasticity in the adolescent development of executive function. Transl Psychiatry 3: e238.
358. Sen S, Burmeister M, Ghosh D (2004). Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 127B: 85-89.
359. Seo D, Patrick CJ, Kennealy PJ (2008). Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Behav 13: 383-395.
360. Shah MP, Wang F, Kalmar JH, Chepenik LG, Tie K, Pittman B et al (2009). Role of variation in the serotonin transporter protein gene (SLC6A4) in trait disturbances in the ventral anterior cingulate in bipolar disorder. Neuropsychopharmacology 34: 1301-1310.
361. Shaikh MB, De Lanerolle NC, Siegel A (1997). Serotonin 5-HT1A and 5-HT2/1C receptors in the midbrain periaqueductal gray differentially modulate defensive rage behavior elicited from the medial hypothalamus of the cat. Brain Res 765: 198-207.
362. Shatz CJ, Stryker MP (1988). Prenatal tetrodotoxin infusion blocks segregation of retinogeniculate afferents. Science 242: 87-89.
363. Siegel A, Shaikh MB (1997). The neural bases of aggression and rage in the cat. Aggress Violent Beh 2: 241-271.
364. Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA et al (1999). d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 20: 413-423.
365. Sijbesma H, Schipper J, de Kloet ER, Mos J, van Aken H, Olivier B (1991). Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine. Pharmacol Biochem Behav 38: 447-458.
366. Silva BA, Mattucci C, Krzywkowski P, Murana E, Illarionova A, Grinevich V et al (2013). Independent hypothalamic circuits for social and predator fear. Nat Neurosci 16: 1731-1733.
367. Simon GE, Cunningham ML, Davis RL (2002). Outcomes of prenatal antidepressant exposure. Am J Psychiatry 159: 2055-2061.
368. Singh JP, Volavka J, Czobor P, Van Dorn RA (2012). A meta-analysis of the Val158Met COMT polymorphism and violent behavior in schizophrenia. PLoS One 7: e43423.
369. Smit-Rigter LA, Noorlander CW, von Oerthel L, Chameau P, Smidt MP, van Hooft JA (2012). Prenatal fluoxetine exposure induces life-long serotonin 5-HT(3) receptordependent cortical abnormalities and anxiety-like behaviour. Neuropharmacology 62: 865-870.
370. Smit-Rigter LA, Wadman WJ, van Hooft JA (2011). Alterations in apical dendrite bundling in the somatosensory cortex of 5-HT(3A) receptor knockout mice. Front Neuroanat 5: 64.
371. Soderstrom H, Blennow K, Manhem A, Forsman A (2001). CSF studies in violent offenders. I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy. J Neural Transm 108: 869-878.
372. Sodetz FJ, Bunnell BN (1970). Septal ablation and the social behavior of the golden hamster. Physiol Behav 5: 79-88.
373. Sodhi MS, Sanders-Bush E (2004). Serotonin and brain development. Int Rev Neurobiol 59: 111-174.
374. Sokolov BP, Cadet JL (2006). Methamphetamine causes alterations in the MAP kinase-related pathways in the brains of mice that display increased aggressiveness. Neuropsychopharmacology 31: 956-966.
375. Sokolov BP, Schindler CW, Cadet JL (2004). Chronic methamphetamine increases fighting in mice. Pharmacol Biochem Behav 77: 319-326.
376. Soloff PH, Price JC, Meltzer CC, Fabio A, Frank GK, Kaye WH (2007). 5HT2A receptor binding is increased in borderline personality disorder. Biol Psychiatry 62: 580-587.
377. Spivak B, Vered Y, Graff E, Blum I, Mester R, Weizman A (1999). Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder. Biol Psychiatry 45: 840-845.
378. Sretavan DW, Shatz CJ (1986). Prenatal development of retinal ganglion cell axons: segregation into eye-specific layers within the cat's lateral geniculate nucleus. J Neurosci 6: 234-251.
379. Stoltenberg SF, Twitchell GR, Hanna GL, Cook EH, Fitzgerald HE, Zucker RA et al (2002). Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. Am J Med Genet 114: 230-234.
380. Strous RD, Nolan KA, Lapidus R, Diaz L, Saito T, Lachman HM (2003). Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. Am J Med Genet B Neuropsychiatr Genet 120B: 29-34.
381. Sundstrom E, Kolare S, Souverbie F, Samuelsson EB, Pschera H, Lunell NO et al (1993). Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimester. Brain Res Dev Brain Res 75: 1-12.
382. Suri D, Veenit V, Sarkar A, Thiagarajan D, Kumar A, Nestler EJ et al (2013). Early stress evokes age-dependent biphasic changes in hippocampal neurogenesis, BDNF expression, and cognition. Biol Psychiatry 73: 658-666.
383. Sweidan S, Edinger H, Siegel A (1991). D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat. Brain Res 549: 127-137.
384. Tadic A, Rujescu D, Szegedi A, Giegling I, Singer P, Moller HJ et al (2003). Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet B Neuropsychiatr Genet 117B: 1-6.
385. Takahashi H, Nakashima S, Ohama E, Takeda S, Ikuta F (1986). Distribution of serotonin-containing cell bodies in the brainstem of the human fetus determined with immunohistochemistry using antiserotonin serum. Brain Dev 8: 355-365.
386. Tarazi FI, Tomasini EC, Baldessarini RJ (1998a). Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi. Neurosci Lett 254: 21-24.
387. Tarazi FI, Tomasini EC, Baldessarini RJ (1998b). Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. Brain Res Dev Brain Res 110: 227-233.
388. Teicher MH, Andersen SL, Hostetter JC Jr. (1995). Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Brain Res Dev Brain Res 89: 167-172.
389. Thierry AM, Le Douarin C, Penit J, Ferron A, Glowinski J (1986). Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons on the activity of cells in the rat prefrontal cortex. Brain Res Bull 16: 155-160.
390. Thompson I, Holt C (1989). Effects of intraocular tetrodotoxin on the development of the retinocollicular pathway in the Syrian hamster. J Comp Neurol 282: 371-388.
391. Tidey JW, Miczek KA (1996). Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res 721: 140-149.
392. Toda T, Homma D, Tokuoka H, Hayakawa I, Sugimoto Y, Ichinose H et al (2013). Birth regulates the initiation of sensory map formation through serotonin signaling. Dev Cell 27: 32-46.
393. Toth M, Fuzesi T, Halasz J, Tulogdi A, Haller J (2010). Neural inputs of the hypothalamic 'aggression area' in the rat. Behav Brain Res 215: 7-20.
394. Tremblay RE, Szyf M (2010). Developmental origins of chronic physical aggression and epigenetics. Epigenomics 2: 495-499.
395. Tsang D, Ho KP, Wen HL (1986). Ontogenesis of multiple forms of monoamine oxidase in rat brain regions and liver. Dev Neurosci 8: 243-250.
396. Tye KM, Prakash R, Kim SY, Fenno LE, Grosenick L, Zarabi H et al (2011). Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 471: 358-362.
397. Underwood MD, Kassir SA, Bakalian MJ, Galfalvy H, Mann JJ, Arango V (2012). Neuron density and serotonin receptor binding in prefrontal cortex in suicide. Int J Neuropsychopharmacol 15: 435-447.
398. Upton AL, Ravary A, Salichon N, Moessner R, Lesch KP, Hen R et al (2002). Lack of 5-HT(1B) receptor and of serotonin transporter have different effects on the segregation of retinal axons in the lateral geniculate nucleus compared to the superior colliculus. Neuroscience 111: 597-610.
399. Upton AL, Salichon N, Lebrand C, Ravary A, Blakely R, Seif I et al (1999). Excess of serotonin (5-HT) alters the segregation of ispilateral and contralateral retinal projections in monoamine oxidase A knock-out mice: possible role of 5-HT uptake in retinal ganglion cells during development. J Neurosci 19: 7007-7024.
400. van Erp AM, Miczek KA (2000). Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. J Neurosci 20: 9320-9325.
401. Van Horn JD, Irimia A, Torgerson CM, Chambers MC, Kikinis R, Toga AW (2012). Mapping connectivity damage in the case of Phineas Gage. PLoS One 7: e37454.
402. van Kleef ES, Gaspar P, Bonnin A (2012). Insights into the complex influence of 5-HT signaling on thalamocortical axonal system development. Eur J Neurosci 35: 1563-1572.
403. Verney C, Lebrand C, Gaspar P (2002). Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter. Anat Rec 267: 87-93.
404. Vinkers CH, Oosting RS, van Bogaert MJ, Olivier B, Groenink L (2010). Early-life blockade of 5-HT(1A) receptors alters adult anxiety behavior and benzodiazepine sensitivity. Biol Psychiatry 67: 309-316.
405. Virkkunen M, Goldman D, Nielsen DA, Linnoila M (1995). Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J Psychiatry Neurosci 20: 271-275.
406. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C et al (1994). CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 51: 20-27.
407. Vitalis T, Ansorge MS, Dayer AG (2013). Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT3A and 5-HT6 receptor subtypes. Front Cell Neurosci 7: 93.
408. Vitalis T, Cases O, Callebert J, Launay JM, Price DJ, Seif I et al (1998). Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period. J Comp Neurol 393: 169-184.
409. Vogel G, Neill D, Hagler M, Kors D (1990). A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev 14: 85-91.
410. Volavka J, Bilder R, Nolan K (2004a). Catecholamines and aggression: the role of COMT and MAO polymorphisms. Ann N Y Acad Sci 1036: 393-398.
411. Volavka J, Czobor P, Nolan K, Sheitman B, Lindenmayer JP, Citrome L et al (2004b). Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychopharmacol 24: 225-228.
412. Volavka J, Kennedy JL, Ni X, Czobor P, Nolan K, Sheitman B et al (2004c). COMT158 polymorphism and hostility. Am J Med Genet B Neuropsychiatr Genet 127B: 28-29.
413. Volkow ND, Tancredi LR, Grant C, Gillespie H, Valentine A, Mullani N et al (1995). Brain glucose metabolism in violent psychiatric patients: a preliminary study. Psychiatry Res 61: 243-253.
414. Volman I, Verhagen L, den Ouden HE, Fernandez G, Rijpkema M, Franke B et al (2013). Reduced serotonin transporter availability decreases prefrontal control of the amygdala. J Neurosci 33: 8974-8979.
415. Wals M, Verhulst F (2005). Child and adolescent antecedents of adult mood disorders. Curr Opin Psychiatry 18: 15-19.
416. Wasman M, Flynn JP (1962). Directed attack elicited from hypothalamus. Arch Neurol 6: 220-227.
417. Watt MJ, Burke AR, Renner KJ, Forster GL (2009). Adolescent male rats exposed to social defeat exhibit altered anxiety behavior and limbic monoamines as adults. Behav Neurosci 123: 564-576.
418. Weaver KJ, Paul IA, Lin RC, Simpson KL (2010). Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects. Anat Rec (Hoboken) 293: 1920-1932.
419. Weisstaub NV, Zhou M, Lira A, Lambe E, Gonzalez-Maeso J, Hornung JP et al (2006). Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313: 536-540.
420. Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R et al (2007). Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci 27: 684-691.
421. Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O et al (2000). [123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry 47: 482-489.
422. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW (2004). 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) 176: 376-385.
423. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Brady K et al (2009). Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry 66: 1201-1209.
424. Yoon Y, McKenna MC, Rollins DA, Song M, Nuriel T, Gross SS et al (2013). Anxietyassociated alternative polyadenylation of the serotonin transporter mRNA confers translational regulation by hnRNPK. Proc Natl Acad Sci USA 110: 11624-11629.
425. Yu Q, Teixeira CM, Mahadevia D, Huang Y, Balsam D, Mann JJ et al (2014). Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice. Mol Psychiatry 19: 688-698.
426. Zalsman G, Huang YY, Harkavy-Friedman JM, Oquendo MA, Ellis SP, Mann JJ (2005). Relationship of MAO-A promoter (u-VNTR) and COMT (V158M) gene polymorphisms to CSF monoamine metabolites levels in a psychiatric sample of caucasians: A preliminary report. Am J Med Genet B Neuropsychiatr Genet 132B: 100-103.
427. Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA et al (2006). Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 163: 1588-1593.
428. Zhang ZW (2003). Serotonin induces tonic firing in layer V pyramidal neurons of rat prefrontal cortex during postnatal development. J Neurosci 23: 3373-3384.
429. Zhuang X, Gross C, Santarelli L, Compan V, Trillat AC, Hen R (1999). Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 21(2 Suppl): 52S-60S.
430. Zill P, Buttner A, Eisenmenger W, Moller HJ, Bondy B, Ackenheil M (2004). Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry 56: 581-586.